{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:08:13Z","timestamp":1790208493738,"version":"4.1.0"},"reference-count":70,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,6]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Onchocerciasis and lymphatic filariasis (LF) are human filarial diseases belonging to the group of neglected tropical diseases, leading to permanent and long-term disability in infected individuals in the endemic countries such as Africa and India. Microfilaricidal drugs such as ivermectin and albendazole have been used as the standard therapy in filariasis, although their efficacy in eliminating the diseases is not fully established. Anti-\n                      <jats:italic toggle=\"yes\">Wolbachia<\/jats:italic>\n                      therapy employs antibiotics and is a promising approach showing potent macrofilaricidal activity and also prevents embryogenesis. This has translated to clinical benefits resulting in successful eradication of microfilarial burden, thus averting the risk of adverse events from target species as well as those due to co-infection with loiasis. Doxycycline shows potential as an anti-\n                      <jats:italic toggle=\"yes\">Wolbachia<\/jats:italic>\n                      treatment, leading to the death of adult parasitic worms. It is readily available, cheap and safe to use in adult non-pregnant patients. Besides doxycycline, several other potential antibiotics are also being investigated for the treatment of LF and onchocerciasis. This review aims to discuss and summarise recent developments in the use of anti-\n                      <jats:italic toggle=\"yes\">Wolbachia<\/jats:italic>\n                      drugs to treat onchocerciasis and LF.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_454_17","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T06:17:29Z","timestamp":1567491449000},"page":"706-714","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":36,"title":["Anti-Wolbachia therapy for onchocerciasis &amp; lymphatic filariasis"],"prefix":"10.25259","volume":"149","author":[{"given":"Wan Aliaa","family":"Wan Sulaiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kamtchum-Tatuene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Hazmi","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasudevan","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Mooi","family":"Ching","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sazlyna Mohd","family":"Sazlly Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnur Zaman","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyana Najwa","family":"Inche Mat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan Kee","family":"Hoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamidon","family":"Basri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-4-20241212","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(10)60586-7","article-title":"Lymphatic filariasis and onchocerciasis","volume":"376","author":"Taylor","year":"2010","journal-title":"Lancet"},{"key":"R4-4-20241212","doi-asserted-by":"crossref","first-page":"E497","DOI":"10.1371\/journal.pntd.0000497","article-title":"Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: First evidence from studies in Mali and Senegal","volume":"3","author":"Diawara","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"R5-4-20241212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1179\/000349804225003253","article-title":"An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana","volume":"98","author":"Awadzi","year":"2004","journal-title":"Ann Trop Med Parasitol"},{"key":"R6-4-20241212","doi-asserted-by":"crossref","first-page":"E998","DOI":"10.1371\/journal.pntd.0000998","article-title":"Phenotypic evidence of emerging ivermectin resistance in Onchocerca volvulus","volume":"5","author":"Osei-Atweneboana","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"R7-4-20241212","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1586\/14787210.4.2.211","article-title":"New strategies to combat filariasis","volume":"4","author":"Hoerauf","year":"2006","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R8-4-20241212","first-page":"329","article-title":"Studies on rickettsia-like micro-organisms in insects","volume":"44","author":"Hertig","year":"1924","journal-title":"J Med Res"},{"key":"R9-4-20241212","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1128\/JB.00269-07","article-title":"A robust species tree for the alphaproteobacteria","volume":"189","author":"Williams","year":"2007","journal-title":"J Bacteriol"},{"key":"R10-4-20241212","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpara.2003.10.004","article-title":"Mapping the presence of Wolbachia pipientis on the phylogeny of filarial nematodes: Evidence for symbiont loss during evolution","volume":"34","author":"Casiraghi","year":"2004","journal-title":"Int J Parasitol"},{"key":"R11-4-20241212","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2883-2-9","article-title":"Evidence against Wolbachia symbiosis in Loa loa","volume":"2","author":"McGarry","year":"2003","journal-title":"Filaria J"},{"key":"R12-4-20241212","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1645\/0022-3395(2002)088[1248:TFEWSI]2.0.CO;2","article-title":"The filarial endosymbiont Wolbachia sp. is absent from Setariaequina","volume":"88","author":"Chirgwin","year":"2002","journal-title":"J Parasitol"},{"key":"R13-4-20241212","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0166-6851(95)02494-8","article-title":"Molecular evidence for a close relative of the arthropod endosymbiont Wolbachia in a filarial worm","volume":"74","author":"Sironi","year":"1995","journal-title":"Mol Biochem Parasitol"},{"key":"R14-4-20241212","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/expr.1998.4383","article-title":"16S rDNA phylogeny and ultrastructural characterization of Wolbachia intracellular bacteria of the filarial nematodes Brugia malayi, B.pahangi, and Wuchereria bancrofti","volume":"91","author":"Taylor","year":"1999","journal-title":"Exp Parasitol"},{"key":"R15-4-20241212","doi-asserted-by":"crossref","first-page":"E121","DOI":"10.1371\/journal.pbio.0030121","article-title":"The Wolbachia genome of Brugia malayi: Endosymbiont evolution within a human pathogenic nematode","volume":"3","author":"Foster","year":"2005","journal-title":"PLoS Biol"},{"key":"R16-4-20241212","doi-asserted-by":"crossref","first-page":"E1002351","DOI":"10.1371\/journal.ppat.1002351","article-title":"Anti-filarial activity of antibiotic therapy is due to extensive apoptosis after Wolbachia depletion from filarial nematodes","volume":"7","author":"Landmann","year":"2011","journal-title":"PLoS Pathog"},{"key":"R17-4-20241212","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1286-4579(00)01269-7","article-title":"Lipopolysaccharide-like molecules derived from Wolbachia endobacteria of the filarial Onchocerca volvulus are candidate mediators in the sequence of inflammatory and antiinflammatory responses of human monocytes","volume":"2","author":"Brattig","year":"2000","journal-title":"Microbes Infect"},{"key":"R18-4-20241212","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.M901528200","article-title":"Wolbachia lipoprotein stimulates innate and adaptive immunity through toll-like receptors 2 and 6 to induce disease manifestations of filariasis","volume":"284","author":"Turner","year":"2009","journal-title":"J Biol Chem"},{"key":"R19-4-20241212","first-page":"2293","article-title":"A worm's best friend: Recruitment of neutrophils by Wolbachia confounds eosinophil degranulation against the filarial nematode Onchocerca ochengi","volume":"278","author":"Hansen","year":"2011","journal-title":"Proc Biol Sci"},{"key":"R20-4-20241212","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1348-0421.2009.00172.x","article-title":"Serum antibody responses to Wolbachia surface protein in patients with human lymphatic filariasis","volume":"53","author":"Shiny","year":"2009","journal-title":"Microbiol Immunol"},{"key":"R21-4-20241212","doi-asserted-by":"crossref","first-page":"E1002749","DOI":"10.1371\/journal.ppat.1002749","article-title":"Circulating microbial products and acute phase proteins as markers of pathogenesis in lymphatic filarial disease","volume":"8","author":"Anuradha","year":"2012","journal-title":"PLoS Pathog"},{"key":"R22-4-20241212","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1286-4579(01)01399-5","article-title":"Neutrophil accumulation around Onchocerca worms and chemotaxis of neutrophils are dependent on Wolbachia endobacteria","volume":"3","author":"Brattig","year":"2001","journal-title":"Microbes Infect"},{"key":"R23-4-20241212","doi-asserted-by":"crossref","first-page":"5908","DOI":"10.1128\/IAI.00991-07","article-title":"Toll-like receptor 2 regulates CXC chemokine production and neutrophil recruitment to the cornea in Onchocerca volvulus\/Wolbachia-induced keratitis","volume":"75","author":"Gillette-Ferguson","year":"2007","journal-title":"Infect Immun"},{"key":"R24-4-20241212","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: Update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"R25-4-20241212","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1128\/IAI.00671-08","article-title":"Gamma interferon and interleukin-1 receptor 1 regulate neutrophil recruitment to the corneal stroma in a murine model of Onchocerca volvulus keratitis","volume":"77","author":"Gentil","year":"2009","journal-title":"Infect Immun"},{"key":"R26-4-20241212","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1128\/CMR.00057-10","article-title":"Onchocerciasis: The role of Wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment","volume":"24","author":"Tamarozzi","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"R27-4-20241212","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00430-002-0174-6","article-title":"Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production","volume":"192","author":"Hoerauf","year":"2003","journal-title":"Med Microbiol Immunol"},{"key":"R28-4-20241212","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/cid\/cis486","article-title":"Doxycycline improves filarial lymphedema independent of active filarial infection: A randomized controlled trial","volume":"55","author":"Mand","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R29-4-20241212","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.2009.09-0155","article-title":"Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine","volume":"81","author":"Mand","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"R30-4-20241212","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1128\/IAI.71.12.6986-6994.2003","article-title":"Removal of Wolbachia from Brugia pahangi is closely linked to worm death and fecundity but does not result in altered lymphatic lesion formation in Mongolian gerbils (Meriones unguiculatus)","volume":"71","author":"Chirgwin","year":"2003","journal-title":"Infect Immun"},{"key":"R31-4-20241212","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1172\/JCI4768","article-title":"Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility","volume":"103","author":"Hoerauf","year":"1999","journal-title":"J Clin Invest"},{"key":"R32-4-20241212","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/ismej.2013.192","article-title":"Integrated transcriptomic and proteomic analysis of the global response of Wolbachia to doxycycline-induced stress","volume":"8","author":"Darby","year":"2014","journal-title":"ISME J"},{"key":"R33-4-20241212","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0140-6736(00)02095-X","article-title":"Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis","volume":"355","author":"Hoerauf","year":"2000","journal-title":"Lancet"},{"key":"R34-4-20241212","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/S0140-6736(05)66591-9","article-title":"Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: A double-blind, randomised placebo-controlled trial","volume":"365","author":"Taylor","year":"2005","journal-title":"Lancet"},{"key":"R35-4-20241212","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/cid\/ciu1152","article-title":"Therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindness","volume":"60","author":"Walker","year":"2015","journal-title":"Clin Infect Dis"},{"key":"R37-4-20241212","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1017\/S0031182013001108","article-title":"Anti-Wolbachia drug discovery and development: Safe macrofilaricides for onchocerciasis and lymphatic filariasis","volume":"141","author":"Taylor","year":"2014","journal-title":"Parasitology"},{"key":"R38-4-20241212","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(00)04581-5","article-title":"Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment","volume":"357","author":"Hoerauf","year":"2001","journal-title":"Lancet"},{"key":"R39-4-20241212","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00430-007-0062-1","article-title":"Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: A randomized placebo-controlled study","volume":"197","author":"Hoerauf","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"R40-4-20241212","doi-asserted-by":"crossref","first-page":"e660","DOI":"10.1371\/journal.pntd.0000660","article-title":"Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: A randomized controlled trial","volume":"4","author":"Turner","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"R41-4-20241212","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00436-008-1217-8","article-title":"Efficacy of 5-week doxycycline treatment on adult Onchocerca volvulus","volume":"104","author":"Hoerauf","year":"2009","journal-title":"Parasitol Res"},{"key":"R43-4-20241212","first-page":"34","article-title":"Effects of ivermectin with and without doxycycline on clinical symptoms of onchocerciasis","volume":"19","author":"Masud","year":"2009","journal-title":"J Coll Physicians Surg Pak"},{"key":"R44-4-20241212","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1086\/501351","article-title":"A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection","volume":"42","author":"Turner","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R45-4-20241212","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1371\/journal.ppat.0020092","article-title":"Doxycycline reduces plasma VEGF-C\/sVEGFR-3 and improves pathology in lymphatic filariasis","volume":"2","author":"Debrah","year":"2006","journal-title":"PLoS Pathog"},{"key":"R47-4-20241212","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1086\/462426","article-title":"Antibiotic chemotherapy of onchocerciasis: In a bovine model, killing of adult parasites requires a sustained depletion of endosymbiotic bacteria (Wolbachia species)","volume":"192","author":"Gilbert","year":"2005","journal-title":"J Infect Dis"},{"key":"R48-4-20241212","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1128\/AAC.50.3.922-927.2006","article-title":"Rate of elimination of Wolbachia pipientis by doxycycline in vitro increases following drug withdrawal","volume":"50","author":"Makepeace","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"R49-4-20241212","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1128\/AAC.01995-13","article-title":"Efficacy of three-week oxytetracycline or rifampin monotherapy compared with a combination regimen against the filarial nematode Onchocerca ochengi","volume":"58","author":"Bah","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"R50-4-20241212","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1756-3305-2-39","article-title":"Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon","volume":"2","author":"Wanji","year":"2009","journal-title":"Parasit Vectors"},{"key":"R51-4-20241212","doi-asserted-by":"crossref","first-page":"A16","DOI":"10.1111\/j.1365-3156.2004.01210.x","article-title":"Economic evaluation of Mectizan distribution","volume":"9","author":"Waters","year":"2004","journal-title":"Trop Med Int Health"},{"key":"R52-4-20241212","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/425001","article-title":"An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis","volume":"39","author":"Suputtamongkol","year":"2004","journal-title":"Clin Infect Dis"},{"key":"R53-4-20241212","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1592\/phco.2006.26.1.3","article-title":"Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents","volume":"26","author":"Brouillard","year":"2006","journal-title":"Pharmacotherapy"},{"key":"R55-4-20241212","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/00034983.2000.11813605","article-title":"Antibiotics and Wolbachia in filarial nematodes: Antifilarial activity of rifampicin, oxytetracycline and chloramphenicol against Onchocerca gutturosa, Onchocerca lienalis and Brugia pahangi","volume":"94","author":"Townson","year":"2000","journal-title":"Ann Trop Med Parasitol"},{"key":"R56-4-20241212","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1046\/j.1365-3156.2003.01040.x","article-title":"Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): Comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability","volume":"8","author":"Volkmann","year":"2003","journal-title":"Trop Med Int Health"},{"key":"R57-4-20241212","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1645\/0022-3395(2002)088[0605:IVEOAO]2.0.CO;2","article-title":"In vitro effects of antibiotics on Brugia malayi worm survival and reproduction","volume":"88","author":"Rao","year":"2002","journal-title":"J Parasitol"},{"key":"R58-4-20241212","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00436-008-0964-x","article-title":"Effects of 6-week azithromycin treatment on the Wolbachia endobacteria of Onchocerca volvulus","volume":"103","author":"Hoerauf","year":"2008","journal-title":"Parasitol Res"},{"key":"R59-4-20241212","doi-asserted-by":"crossref","first-page":"878","DOI":"10.4269\/ajtmh.2007.77.878","article-title":"No depletion of Wolbachia from Onchocerca volvulus after a short course of rifampin and\/or azithromycin","volume":"77","author":"Richards","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"R60-4-20241212","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-0034-1543955","article-title":"Rifampin use and safety in hospitalized infants","volume":"32","author":"Arnold","year":"2015","journal-title":"Am J Perinatol"},{"key":"R61-4-20241212","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00436-008-1133-y","article-title":"Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus","volume":"103","author":"Specht","year":"2008","journal-title":"Parasitol Res"},{"key":"R62-4-20241212","doi-asserted-by":"crossref","first-page":"E9712","DOI":"10.1073\/pnas.1710845114","article-title":"Albendazole and antibiotics synergize to deliver short-course anti-Wolbachia curative treatments in preclinical models of filariasis","volume":"114","author":"Turner","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R63-4-20241212","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ja.2014.107","article-title":"Resistance to rifampicin: A review","volume":"67","author":"Goldstein","year":"2014","journal-title":"J Antibiot (Tokyo"},{"key":"R64-4-20241212","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41598-017-00322-5","article-title":"Short-course, high-dose rifampicin achieves Wolbachia depletion predictive of curative outcomes in preclinical models of lymphatic filariasis and onchocerciasis","volume":"7","author":"Aljayyoussi","year":"2017","journal-title":"Sci Rep"},{"key":"R65-4-20241212","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: Far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br J Pharmacol"},{"key":"R66-4-20241212","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1475-2883-5-4","article-title":"Onchocerca parasites and Wolbachia endosymbionts: Evaluation of a spectrum of antibiotic types for activity against Onchocerca gutturosa in vitro","volume":"5","author":"Townson","year":"2006","journal-title":"Filaria J"},{"key":"R67-4-20241212","doi-asserted-by":"crossref","first-page":"23458","DOI":"10.1038\/srep23458","article-title":"Minocycline as a re-purposed anti-Wolbachia macrofilaricide: Superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis","volume":"6","author":"Sharma","year":"2016","journal-title":"Sci Rep"},{"key":"R68-4-20241212","doi-asserted-by":"crossref","first-page":"e0005156","DOI":"10.1371\/journal.pntd.0005156","article-title":"Comparison of doxycycline, minocycline, doxycycline plus albendazole and albendazole alone in their efficacy against onchocerciasis in a randomized, open-label, pilot trial","volume":"11","author":"Klarmann-Schulz","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"R69-4-20241212","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7164\/antibiotics.38.145","article-title":"The corallopyronins, new inhibitors of bacterial RNA synthesis from myxobacteria","volume":"38","author":"Irschik","year":"1985","journal-title":"J Antibiot (Tokyo"},{"key":"R70-4-20241212","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/infdis\/jis341","article-title":"Corallopyronin A specifically targets and depletes essential obligate Wolbachia endobacteria from filarial nematodes in vivo","volume":"206","author":"Schiefer","year":"2012","journal-title":"J Infect Dis"},{"key":"R71-4-20241212","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijmm.2013.08.010","article-title":"Corallopyronin A \u2013 A promising antibiotic for treatment of filariasis","volume":"304","author":"Sch\u00e4berle","year":"2014","journal-title":"Int J Med Microbiol"},{"key":"R73-4-20241212","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijpddr.2014.09.001","article-title":"Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis","volume":"4","author":"Johnston","year":"2014","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"R74-4-20241212","doi-asserted-by":"crossref","first-page":"e1411","DOI":"10.1371\/journal.pntd.0001411","article-title":"Targeting the Wolbachia cell division protein FtsZ as a new approach for antifilarial therapy","volume":"5","author":"Li","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"key":"R75-4-20241212","doi-asserted-by":"crossref","first-page":"E1638","DOI":"10.1073\/pnas.1203519109","article-title":"Autophagy regulates Wolbachia populations across diverse symbiotic associations","volume":"109","author":"Voronin","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R76-4-20241212","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1756-3305-3-99","article-title":"Lipoprotein biosynthesis as a target for anti-Wolbachia treatment of filarial nematodes","volume":"3","author":"Johnston","year":"2010","journal-title":"Parasit Vectors"},{"key":"R77-4-20241212","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1371\/journal.pntd.0000475","article-title":"The heme biosynthetic pathway of the obligate Wolbachia endosymbiont of Brugia malayi as a potential anti-filarial drug target","volume":"3","author":"Wu","year":"2009","journal-title":"PLoS Negl Trop Dis"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201949060-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:01:47Z","timestamp":1751482907000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/anti-wolbachia-therapy-for-onchocerciasis-lymphatic-filariasis-current-perspectives\/"}},"subtitle":["Current perspectives"],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_454_17","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]}}}